In May, markets stayed choppy, while Healthcare was able to further extend its outperformance versus global equities. Earnings season is almost concluded and trends outlined in last month’s report held
true. Our chart of the month focuses on the huge M&A firepower of large biopharma companies.
Detecting cancer early on can make such a big difference. The good news is that cancer screening will get much easier in the future.
February was a month of twists and turns for the healthcare industry! From the ebb and flow of macro dynamics to the ups and downs of the Q4 reporting season, healthcare stocks experienced a flurry of activity. Meanwhile, the Medtech, Pharma, and Providers space saw a surge of M&A activity. More in this month’s commentary.
Did you know that every 34 seconds a person dies in the United States from cardiovascular disease? It’s the leading cause not only in the US, but also globally.